Jun Hung Cho, Ph.D., RAC(Drugs)

Principal Scientist at ADMA Biologics, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Boca Raton, Florida, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 100 - 200 Employee
    • Principal Scientist
      • Nov 2022 - Present

      Boca Raton, Florida, United States

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Principal Scientist
      • Aug 2021 - Oct 2022

      Boca Raton, Florida, United States

    • Senior Scientist
      • Feb 2019 - Jul 2021

      Boca Raton, Florida • Support product development efforts in the process development and manufacturing areas. • Responsible for producing high-quality data and reports suitable for company and client development and patent/paper publication. • Advise project management progress and help interact with clients to resolve product issues. • Effectively managed research plans and help multiple grants submitting and external research collaborations including experimental design, planning, and reporting, etc.

    • United States
    • Higher Education
    • 700 & Above Employee
    • Senior Research Associate,phD (Postdoctoral Scholar)
      • Jul 2012 - Feb 2019

      Abilene, Texas Area •Established how cell differentiation regulated at AML: Construct Lentivirus shRNA stable cell lines to address RHEB involve in cell fate.. .•Setting up lab CRISPR screening system: expertise in deletion and one nucleotide exchange by HDR/NHEJ. • Discovery NOTCH1 to RHEB vicious loop to maintain stem cell progenitor status at LAM and AML cells. •Study design, Search Literature and idea provider, Technical training and supervision of junior research staff • Characterization of TSC… Show more •Established how cell differentiation regulated at AML: Construct Lentivirus shRNA stable cell lines to address RHEB involve in cell fate.. .•Setting up lab CRISPR screening system: expertise in deletion and one nucleotide exchange by HDR/NHEJ. • Discovery NOTCH1 to RHEB vicious loop to maintain stem cell progenitor status at LAM and AML cells. •Study design, Search Literature and idea provider, Technical training and supervision of junior research staff • Characterization of TSC disease exosome particle leads to disease model generation at Mouse. •My discovery results in Department of Defense funding. Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • phD at Rutgers Pharmacology
      • 2006 - 2012

      NEW Jersey /Piscataway Research topic: • mTOR activity regulation and its novel substrate identification. • The role of TORC1 in regulation of mitochondrial fusion in response to growth signals.. • The identification of novel regulator of mTOR kinase.

    • Taiwan
    • Higher Education
    • 700 & Above Employee
    • Research Associate
      • Jan 2001 - May 2005

      Academia sinica,Taiwan. Research topic: Centrosomal protein regulation. (Centrosome biology, cancer genomic instability.)

Education

  • Rutgers Graduate School of Education
    Doctor of Philosophy - PhD, Pharmacology
    2006 - 2012
  • National Tsing Hua University
    Master, Life Science
    1998 - 2000
  • Rutgers University
    Doctor of Philosophy - PhD, Pharmacology

Community

You need to have a working account to view this content. Click here to join now